Peptides for Muscle growth
The peptides people most often research for muscle growth, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 8
- With human trials
- 6
- FDA approved (any use)
- 2
- CJC-1295GHRH analogHuman observational evidence, 3 of 4Substance use & misuse 2016, PMID 26771670Human1Animal1Summarised2Not FDA approved · research chemicalFor muscle growthOverview
- CJC-1295 + IpamorelinGHRH + GHRP blendHuman observational evidence, 3 of 4CJC-1295: Substance use & misuse 2016, PMID 26771670Human1Animal0Summarised6Not FDA approved · research blendFor muscle growthOverview
- SermorelinGHRH analogHuman observational evidence, 3 of 4American journal of men's health 2017, PMID 28830317Human2Animal0Summarised3Compounded by prescriptionFor muscle growthOverview
- IGF-1 LR3IGF-1 analogAnimal evidence, 2 of 4American journal of physiology. Endocrinology and metabolism 2025, PMID 39679943Human0Animal6Summarised8Not FDA approved · research chemicalFor muscle growthOverview
- HGHRecombinant growth hormoneHuman RCT evidence, 4 of 4Journal of applied physiology 2014, PMID 24235105Human767Animal80Summarised9FDA approved (prescription only)For muscle growthOverview
- EnclomipheneSERM (not a peptide)No study with an outcome for muscle growthPubMed search, 11 Oct 2026Human0Animal0Summarised0Not FDA approved · compoundedFor muscle growthOverview
- hCGGonadotropinHuman RCT evidence, 4 of 4The Journal of clinical endocrinology and metabolism 2002, PMID 12107212Human19Animal2Summarised2FDA approved (prescription only)For muscle growthOverview
- MOTS-cMitochondrial-derived peptideHuman RCT evidence, 4 of 4Medicine and science in sports and exercise 2025, PMID 40674654Human6Animal2Summarised4PCAC voted 7–5 for 503A (Jul 2026)For muscle growthOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What muscle growth takes, according to NIH
MedlinePlus describes exercise as anything that gets the body moving.[12]
Human data is concentrated in one hormone, not the peptides people search for
Growth hormone accounts for 767 human-only papers on the muscle-growth topic and 246 randomised trials, whereas CJC-1295, sermorelin and the CJC/ipamorelin blend have 1 or 2 each and IGF-1 LR3 has six animal papers and no human ones.
Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); cjc-1295 human only 1, animal only 1, rct 0; cjc-1295-ipamorelin human only 1, animal only 0, rct 0; sermorelin human only 2, animal only 0, rct 0; igf-1-lr3 human only 0, animal only 6, rct 0; hgh human only 767, animal only 80, rct 246. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.
A recent systematic review of growth hormone in orthopaedic and sports-medicine patients found lean mass up in 15 of 23 studies, with leg extension strength up by a smaller margin than lean mass.[13]
An 18-person randomised trial in older men doing resistance training found no effect of growth hormone on muscle strength.[14]
In a randomised trial of healthy older men, only a single strength measure improved on growth hormone plus testosterone, and the authors describe the strength changes as variable.[15]
MOTS-c has mouse data on muscle preservation: immobilisation cost mice about 15% of muscle mass, while MOTS-c treatment held the loss to 5%.[16]
IGF-1 LR3 results are animal only and inconsistent, with one rat study showing no carcass protein gain.[17]
In pigs, a short infusion of the same peptide lowered average daily gain.[18]
GLP-1 drugs lose some lean mass
In the tirzepatide trial that measured body composition, about 25% of the weight lost was lean mass, the same share as on placebo.[19]
Common questions
What are the best peptides for muscle growth?
Only growth hormone has substantial human trial data among the options here. In the latest review its lean-mass gain came with a smaller strength gain.[13]
Do peptides for muscle gain really work?
The human evidence is for growth hormone and is mixed on strength, and for the research peptides the cited work is in animals.[14]
Is there a peptide stack for muscle growth?
No human trial of a muscle-building stack is cited here; the CJC-1295 material is hormone-release studies and user reports.[1]
Do GLP-1 weight loss drugs cost muscle?
A trial of tirzepatide found most weight lost was fat but a share was lean mass, and a pooled analysis called tirzepatide and semaglutide among the least effective at preserving it.[20]
Explore nearby goals
Sources
- 1Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Substance use & misuse · 2016PMID 26771670Accessed 2 Oct 2026
- 2Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
- 3IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
- 4Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation.Journal of applied physiology (Bethesda, Md. : 1985) · 2014PMID 24235105Accessed 2 Oct 2026
- 5A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency.The Journal of clinical endocrinology and metabolism · 2002PMID 12107212Accessed 2 Oct 2026
- 6Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization.Medicine and science in sports and exercise · 2025PMID 40674654Accessed 2 Oct 2026
- 7PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR "trans-clomiphene"[tiab] (98 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab]) AND humans[mh] (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR Androxal[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 12Official web pageOfficial web page · web page
- 13Human Growth Hormone as a Therapeutic Treatment Option in Orthopaedics: A Systematic Review of Dosing, Side Effects, and Clinical Outcomes.JBJS reviews · 2026PMID 41557825Accessed 2 Oct 2026
- 14Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.The Journal of clinical endocrinology and metabolism · 1994PMID 7525633Accessed 2 Oct 2026
- 15The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.The Journal of clinical endocrinology and metabolism · 2006PMID 16332938Accessed 2 Oct 2026
- 16Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration.American journal of physiology. Endocrinology and metabolism · 2024PMID 38170165Accessed 2 Oct 2026
- 17Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
- 18Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
- 19Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.Diabetes, obesity & metabolism · 2025PMID 39996356Accessed 2 Oct 2026
- 20Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.Metabolism: clinical and experimental · 2025PMID 39719170Accessed 2 Oct 2026
Found an error? Report a correction.